Cardiovascular Agents Concept

subject area of

• 2008 update of international guidelines for the management of severe sepsis and septic shock: should we change our current clinical practice?  Academic Article
• A 30-Year Perspective (1975–2005) Into the Changing Landscape of Patients Hospitalized With Initial Acute Myocardial Infarction  Academic Article
• A 35-year journey to evidence-based medicine: a personal story  Academic Article
• A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community  Academic Article
• A Survey of Stated Physician Practices and Beliefs on the Use of Steroids in Pediatric Fluid and/or Vasoactive Infusion-Dependent Shock*  Academic Article
• A Systematic Review and Meta-Analysis on the Effect of Steroids in Pediatric Shock  Academic Article
• A polypill for cardiovascular disease prevention with a focus on non-alcohol steatohepatitis  Academic Article
• A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants  Academic Article
• ACE inhibitors: back to prime time?  Academic Article
• ACTIONS OF 4-AMINOPYRIDINE ON THE CARDIOVASCULAR SYSTEMS OF ANAESTHETIZED CATS AND DOGS  Academic Article
• Adjunct Therapy in STEMI Intervention  Academic Article
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Academic Article
• American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock  Academic Article
• An Overview of the Clinical Trials of Agents (Other than β-Blockers) That Potentially Limit Myocardial Infarct Size  Academic Article
• Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy  Academic Article
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials  Academic Article
• Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial  Academic Article
• Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention  Academic Article
• CCORT/CCS quality indicators for acute myocardial infarction care.  Academic Article
• CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction  Academic Article
• Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management  Academic Article
• Challenges in the conduct and interpretation of phase II (pilot) randomized trials  Academic Article
• Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition  Academic Article
• Clinical Features, Treatment Practices, and Hospital and Long-Term Outcomes of Older Patients Hospitalized with Decompensated Heart Failure: The Worcester Heart Failure Study  Academic Article
• Cluster randomized controlled trial of Delayed Educational Reminders for Long-term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA-STEMI)  Academic Article
• Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study  Academic Article
• Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges  Academic Article
• Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients  Academic Article
• Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology.  Academic Article
• Contemporary Trends in Evidence-based Treatment for Acute Myocardial Infarction  Academic Article
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Academic Article
• Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial  Academic Article
• Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease  Academic Article
• Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial)  Academic Article
• Exploring the Barriers to and Facilitators of Using Evidence-Based Drugs in the Secondary Prevention of Cardiovascular Diseases: Findings From a Multistakeholder, Qualitative Analysis  Academic Article
• Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial  Academic Article
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Academic Article
• Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial  Academic Article
• Heart failure and cognitive impairment: challenges and opportunities.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart rate and heart failure  Academic Article
• Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials  Academic Article
• How and why a multifaceted intervention to improve adherence post-MI worked for some (and could work better for others): an outcome-driven qualitative process evaluation  Academic Article
• Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction  Academic Article
• Influence of Drugs on Arteriovenous Vascular access Dysfunction  Academic Article
• Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16  Academic Article
• Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol  Academic Article
• Ivabradine: A Current Overview  Academic Article
• Letter to the Editor  Academic Article
• Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes  Academic Article
• Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter  Academic Article
• Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines  Academic Article
• Measurement of both Cyclic [3H]AMP and Cyclic [3H]GMP in Cultured Vascular Smooth Muscle Cells Labeled with [3H]Hypoxanthine: Use in Studies of Cardiovascular Drugs  Academic Article
• Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007  Academic Article
• New-onset atrial fibrillation in adult critically ill patients: a scoping review  Academic Article
• Office management of patients with diastolic heart failure  Academic Article
• Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease  Academic Article
• Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial  Academic Article
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conference Paper
• Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps)  Academic Article
• Patient-Reported Outcome Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments  Academic Article
• Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization  Academic Article
• Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.  Academic Article
• Polypharmacotherapy for primary prevention of cardiovascular disease.  Academic Article
• Polypills  Academic Article
• Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)  Academic Article
• Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease  Academic Article
• Primary care intervention to address cardiovascular disease medication health literacy among Indigenous peoples: Canadian results of a pre-post-design study  Academic Article
• Prophylactic Indomethacin Worsens Short-Term Respiratory Outcomes in Extremely Low-Birth-Weight Infants  Academic Article
• Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial  Academic Article
• Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention  Academic Article
• Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials  Academic Article
• Role of aspirin for prevention and treatment of perioperative cardiovascular events  Academic Article
• Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions  Academic Article
• Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events  Academic Article
• Secondary CV Prevention in South America in a Community Setting: The PURE Study  Academic Article
• Secondary prevention of ischaemic cardiac events.  Academic Article
• Secondary prevention of ischaemic cardiac events.  Academic Article
• Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes  Academic Article
• Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study  Academic Article
• Statistics in cardiovascular medicine: there is still gold in the old  Academic Article
• Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure  Academic Article
• The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population  Academic Article
• The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.  Academic Article
• The Corrected Values for Duration and Frequency of Angina at Baseline in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial  Academic Article
• The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina  Academic Article
• The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia  Academic Article
• The Inotropic Effect of 4−Aminopyridine and pH Changes in Rabbit Papillary Muscle  Academic Article
• The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape  Academic Article
• The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.  Academic Article
• The management of congestive heart failure  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The polypill: from concept and evidence to implementation  Academic Article
• To Thin or Not to Thin: A Case of Peripartum Cardiomyopathy  Academic Article
• Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada  Academic Article
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Academic Article
• Why would a sane clinician not prescribe prophylactic indomethacin?  Academic Article